Do You Need Blood Work Before Starting a GLP-1? What Clinicians May Check

Is blood work required before starting semaglutide or tirzepatide?

There is no single official pre-start lab panel in the FDA labeling for either medication. In practice, a licensed clinician may:

• Ask for recent labs you already have from a primary care visit
• Order new labs when your history raises a question the labs would answer
• Decide labs aren't needed to make a safe starting decision

What clinicians check before a GLP-1, with or without labs

A lot of pre-start screening is history, not blood. The FDA labeling for semaglutide and tirzepatide points clinicians to several areas.

Thyroid history. Both medications carry a boxed warning about thyroid C-cell tumors seen in rodents. Both are contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is a history question. The labeling says routine calcitonin blood tests or thyroid ultrasound are of uncertain value for early detection and can lead to unnecessary procedures, so a "thyroid screen" is not automatically part of starting.

Pancreas and gallbladder history. Acute pancreatitis and gallbladder problems are listed warnings. A prior history of either is something clinicians want to know about up front.

Diabetes and blood sugar. If you have diabetes, the labeling calls for monitoring blood glucose before and during treatment. Hypoglycemia risk is higher when a GLP-1 is combined with insulin or a sulfonylurea, so your current diabetes medications matter.

Kidney function. GLP-1 side effects like nausea, vomiting, or diarrhea can lead to dehydration, and the labeling warns about acute kidney injury from volume depletion. Clinicians may want a baseline kidney picture, especially if you have existing kidney concerns.

Medications and pregnancy plans. These medications slow stomach emptying, which can affect how some oral medications are absorbed. Tirzepatide's labeling advises people using oral birth control to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase. Wegovy's labeling advises stopping at least 2 months before a planned pregnancy. Pregnancy plans belong in your intake.

Common labs before a GLP-1 (when a clinician orders them)

When labs are ordered, they tend to come from a familiar baseline set. These are examples of what clinicians commonly use, not a checklist you need to complete.

• Hemoglobin A1C or fasting glucose: a picture of blood sugar regulation, and important context if prediabetes or diabetes is possible
• Comprehensive metabolic panel (CMP): kidney and liver function plus electrolytes
• Lipid panel: cholesterol and triglycerides, useful cardiometabolic context at baseline
• Complete blood count (CBC): a general health snapshot
• Thyroid function (TSH): sometimes added when symptoms or history make it relevant

Some clinicians also look at markers like fasting insulin, vitamin B12, or vitamin D depending on the person. More tests aren't automatically better. A good lab plan answers a specific clinical question.

Why some people choose baseline labs even when they aren't required

Even when labs aren't needed to start, some patients and clinicians like having a baseline. It can:

• Give follow-up visits something concrete to compare against
• Turn up something worth addressing, like elevated A1C or a lipid pattern, that changes the conversation
• Add context for a clinician deciding between options or pacing a plan

That's the idea behind the lab tests page: biomarkers can help frame a clinical starting point and later follow-up, while interpretation stays with the licensed clinician.

How labs fit into an online GLP-1 pathway

On a clinician-reviewed telehealth pathway, the sequence usually looks like this:

1. Goal-based intake: health history, medications, and the screening questions above
2. Licensed clinician review: the clinician decides whether labs are needed, or whether recent results are enough
3. Partner lab order, if appropriate: samples are collected at a partner lab near you
4. Clinician interpretation: results inform whether therapy fits and how follow-up is paced
5. Prescription only if appropriate, filled through compliant pharmacy channels, with ongoing follow-up

YourHealthRx is an access layer to licensed clinical partners. We don't order or read your labs ourselves. That stays with the clinician responsible for your care.

FAQ

Do I need blood work to get semaglutide or tirzepatide online?

Not always. The FDA labeling doesn't require a set panel, but your clinician may ask for recent labs or order new ones based on your history. A prescription is never guaranteed.

Can I use labs I already had done?

Often, yes. Recent results from your own doctor may be enough. Your clinician decides whether they're current and complete enough.

Will a clinician check my thyroid before a GLP-1?

They will ask about your personal and family thyroid cancer history, which is the key screening question. Routine calcitonin testing isn't recommended in the labeling for early detection.

Do I need labs while I'm on a GLP-1?

That depends on your health and how treatment is going. People with diabetes need glucose monitoring, and clinicians may check kidney function if dehydrating side effects occur. Follow-up labs are a clinical decision.

Are lab tests included in the price?

Lab pricing is determined after clinician review based on what, if anything, is ordered.

Start with a clinician, not a checklist

If you're weighing a GLP-1, the most useful first step is a review of your history by someone licensed to decide what you actually need. You can check your eligibility or explore options by goal. A licensed clinician reviews your intake and decides whether labs, therapy, or neither makes sense for you.